Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

The market for these drugs is expected to grow.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

The new gel improves skin delivery of a drug, potentially reducing dose frequency and side effects.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.

PLX, a tomato extract mix, may help treat prostate issues like BPH.

Blocking Prostaglandin D₂ may help treat hair loss.

The new gel for hair loss is safe, effective, and reduces side effects.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

The method effectively measures drug impact on DHT levels in prostate treatments.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Certain medications, especially Paroxetine, Tamsulosin, and Finasteride, are linked to ejaculatory disorders.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

Finasteride improves urinary symptoms and quality of life in BPH patients, especially with larger prostate size.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.